Advertisement
Advertisement
Cytek Biosciences reports Q3 EPS (4c), consensus 1c
PremiumThe FlyCytek Biosciences reports Q3 EPS (4c), consensus 1c
8d ago
Cytek Biosciences management to meet virtually with Piper Sandler
Premium
The Fly
Cytek Biosciences management to meet virtually with Piper Sandler
3M ago
Cytek Biosciences price target lowered to $4 from $7 at Morgan Stanley
Premium
The Fly
Cytek Biosciences price target lowered to $4 from $7 at Morgan Stanley
3M ago
Cytek Biosciences narrows FY25 revenue view to $196M-$200M from $196M-$210M
PremiumThe FlyCytek Biosciences narrows FY25 revenue view to $196M-$200M from $196M-$210M
3M ago
Cytek Biosciences Elects New Directors at Annual Meeting
Premium
Company Announcements
Cytek Biosciences Elects New Directors at Annual Meeting
5M ago
Cytek Biosciences price target lowered to $7 from $9 at Morgan Stanley
Premium
The Fly
Cytek Biosciences price target lowered to $7 from $9 at Morgan Stanley
6M ago
Cytek Biosciences Faces Revenue Challenges and Market Uncertainty, Downgraded to Hold
PremiumRatingsCytek Biosciences Faces Revenue Challenges and Market Uncertainty, Downgraded to Hold
6M ago
Cytek Biosciences Reports Q1 2025 Financial Results
Premium
Company Announcements
Cytek Biosciences Reports Q1 2025 Financial Results
6M ago
Cytek Biosciences reports Q1 EPS (9c) vs. (5c) last year
Premium
The Fly
Cytek Biosciences reports Q1 EPS (9c) vs. (5c) last year
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100